PercuSense is a development-stage company focused on minimally invasive medical devices that use physiological triggers to continuously monitor and proactively diagnose progression of diseases such as sepsis, cancer or diabetes, ultimately enabling more effective, smart therapy. Our products are based on a first-in-category, calibration-free electrochemical sensor that combines principles of glucose detection inspired by islet cell technology with a novel sensing electrode design that yields a low-profile implant and superior mechanical stability.

– See more at: